✦ LIBER ✦

Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancer

✍ Scribed by C Dittrich; B Coudert; L Paz-Ares; F Caponigro; M Salzberg; T Gamucci; X Paoletti; C Hermans; D Lacombe; P Fumoleau

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of XR5000 (DACA), an inhi

✍ Christian Dittrich; Veronique Dieras; Pierre Kerbrat; Cornelis Punt; Roberto Sor 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 65 KB

A Phase II Trial of 9-Aminocaptothecin (

✍ Everett E. Vokes; Gary S. Gordon; Charles M. Rudin; Ann M. Mauer; Sylvia Watson; 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 62 KB

A phase I/II study of pemetrexed and vin

✍ Clarke, Stephen J.; Boyer, Michael J.; Millward, Michael; Underhill, Craig; Moyl 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 176 KB

136 Single centre phase II trial of pacl

✍ Ranson, M.; Anderson, H.; Jayson, G.; Thatcher, N. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 136 KB

A pharmacokinetic and phase II study of

✍ Lorraine K. Webster; Ian N. Olver; Kerrie H. Stokes; Robert G. Sephton; Brian L. 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 83 KB

Treatment with paclitaxel 1-h infusion a

✍ Helsing, Martin; Thaning, Lars; Sederholm, Christer; Lamberg, Kristina; Martinss 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 106 KB